San Francisco Bay Area biotech stories.
Thursday, February 17, 2011
Ex-CEO Thomas Okarma departing Geron with $1.3 million, consulting deal, stock
Former Geron Corp. President and CEO Thomas Okarma could receive up to $1.3 million, including $802,500 in severance pay, according to an agreement with the Menlo Park-based developer of stem cell treatments.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)